Eliminate the uncertainty of your future
There is an increased likelihood of a BRCA1 or BRCA2 mutation in patients with certain personal and family history characteristics and various clinical criteria. BRCANOW™ is a Next-Gen Sequencing (NGS)-based assay using a state-of-the-art platform to detect whether or not a mutation is present.
Everyone has BRCA1 and BRCA2 genes.
When mutations occur within these genes, a person’s risk of developing specific cancers such as breast and ovarian cancer increases. A parent who has one of these genetic mutations can pass the mutation along to his or her child, thus increasing the child’s risk of developing cancer associated with the mutation.
You have a 50% chance of inheriting BRCA mutation.
BRCA1/2 mutations can be passed or inherited from a mother or a father in an autosomal dominant fashion. This means that having only one copy of a BRCA1/2 mutation can increase your chance of developing certain cancers like breast and ovarian.
If your mother or father carries a BRCA mutation, you have a 50% chance of inheriting that same mutation.
BRCA mutations can occur in males, females, any race or ethnic group.
About 1 in every 500 women in the United States has a mutation in either her BRCA1 or BRCA2 gene.
However, for some ethnic groups, such as the Ashkenazi Jewish population, the risk of carrying a BRCA mutation increases to 1 in 40
How BRCANOW™ testing works
Physician & patient discuss the benefits of BRCANOW™
The test can be performed using blood or saliva
Your Sample is Analyzed
in our Lab
Your BRCANOW™ report will be available within 10-14 days.
We’re here to guide you
through the process.
Part of BRCANOW™ includes genetic counseling to walk you through our process and test results, along with any lifestyle or treatment alternatives depending on your results.